MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer
Gengtai Ye(Key Laboratory of Guangdong Province), Xiaolong Qi(First Hospital of Lanzhou University), Baoxiong Zhuang(Nanfang Hospital), Haipeng Zhou(Nanfang Hospital), Qingbin Yang(Key Laboratory of Guangdong Province), Zhiyong Shen(Nanfang Hospital), Guoxin Li(Nanfang Hospital), Liying Zhao(Second Affiliated Hospital of Zhejiang University), Yuming Jiang(Nanfang Hospital), Lei Zhang(Dalhousie University), Yan Li(Southern Medical University), Xianjun Zhu(University of Electronic Science and Technology of China), Jiang Yu(Southern Medical University), Hao Liu(Nanfang Hospital), Yanfeng Hu(Nanfang Hospital), Da Wang(Kunming Medical University), Haijun Deng(Nanfang Hospital), Kunzhai Huang(Nanfang Hospital), Wende Li(Harvard University)
Cited by 114
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Circular RNA circRHOBTB3 acts as a sponge for miR-654-3p inhibiting gastric cancer growth
|Journal of Experimental & Clinical Cancer Research|2020|269
Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram
|Nature Communications|2021|207